Economic Times - Feb. 2010

Troikaa may get US Patent for New Drug

Troikaa Pharmaceuticals, a Gujarat-based fast growing healthcare company, is likely to get US patent for its novel drug delivery form of Diclofenac injections-Dyanapar AQ.

“Troikaa will soon get US patent for its Dyanapar AQ 1 ml injections, as proceedings at the USFDA have got over. We are just awaiting certificate and confirmation from them,” Troikaa MD Ketan Patel said. Diclofenac injections are used for management of painful inflammatory conditions.